Australia TGA ARTG recordMedication transfer set
Australia TGA ARTG Registered Device · Sanofi-Aventis Australia Pty Ltd · Sanofi Pasteur · Class IIa · Started February 23, 2021
Good Name: Sanofi-Aventis Australia Pty Ltd - Medication transfer set
- Risk Class
- Class IIa
- Product Type
- Procedure Pack
- ARTG Category
- General
- Start Date
- February 23, 2021
- Effective Date
- February 23, 2021
- Name
- Sanofi Pasteur
- Country
- France
- Address
- 1541 Avenue Marcel Merieux, 69280 Marcy L'Etoile
Merieux inactivated rabies vaccine (AUST R 26675) is a vaccine indicated for : Post exposure immunisation against rabies and Pre-exposure immunisation in persons at special risk of contracting rabies. Each pack contains one dose of freeze-dried vaccine in a vial and one dose of 0.4% sodium chloride diluent in a one 1.0 mL syringe and two needles (16mm and 25mm) for reconstitution and administration.
Access comprehensive regulatory information for Medication transfer set in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Sanofi-Aventis Australia Pty Ltd, manufactured by Sanofi Pasteur in France. The device registration started on February 23, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.